Author: Patsy Newitt

Three recent ASC proposals have received opposition from community groups and other healthcare organizations for reasons varying from traffic to excess services at other facilities. 

From patents to FDA clearances, here are four updates on gastrointestinal devices:

Ophthalmology is no exception to the massive private equity push into healthcare. Here are five updates from PE-backed ophthalmology groups:

Owings Mills, Md.-based Chesapeake Urology reached its 1,000th milestone for ambulatory percutaneous nephrolithotomy, the highest number of such procedures in the country, according to a May 5 release.  

Orlando, Fla.-based Nemours Children's Hospitals filed a challenge to the American Health Care Association's proposed rule regulating pediatric cardiac care services, according to WUSF. 

Rockford-based OrthoIllinois' proposed ASC narrowly failed to pass during the Illinois Health Facilities and Services Review Board meeting May 4, Health News Illinois reported May 5.

Implant costs are a burden for many ASCs, and many feel ASCs have irreparably shifted the implant industry. 

Acton, Mass.-based Middlesex Digestive Health & Endoscopy Center launched a new program to help patients manage weight and related gastrointestinal disorders, the company announced May 5. 

Endosoft has been issued a patent for its Argus AI System for detecting and sizing gastrointestinal lesions, the company announced May 4. 

Tampa, Fla.-based Physician Partners of America has named two executives in the past week.